The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis

Cancer Research

Volumn 64, Issue 2, 2004, Pages 581-589

  Verschuren, Emmy W ^a,c   Hodgson, J Graeme ^a   Gray, Joe W ^a   Kogan, Scott ^a   Jones, Nic ^b   Evan, Gerard I ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; K CYCLIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; FEMALE; GENOME; HUMAN HERPESVIRUS 8; IN VIVO STUDY; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE; TUMOR CELL; VIRUS CARCINOGENESIS;

ANIMALS; CELL LINE, TUMOR; CROSSES, GENETIC; CYCLINS; DNA PRIMERS; FEMALE; GENES, P53; GENOTYPE; HERPESVIRUS 8, HUMAN; KINETICS; LYMPHANGIOGENESIS; LYMPHOMA, B-CELL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; PLASMIDS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

EID: 1642556785     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1863     Document Type: Article

References (67)

1. Albrecht, J. C., Nicholas, J., Biller, D., Cameron, K. R., Biesinger, B., Newman, C., Wittmann, S., Craxton, M. A., Coleman, H., Fleckenstein, B., et al. Primary structure of the herpesvirus saimiri genome. J. Virol., 66: 5047-5058, 1992.
2. Virgin, H. W. T., Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J., and Speck, S. H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol., 71: 5894-5904, 1997.
3. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., and Moore, P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA, 93: 14862-14867, 1996.
4. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332: 1186-1191, 1995.
5. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., and Moore, P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (Wash. DC), 266: 1865-1869, 1994.
6. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. F., Clauvel, J. P., Raphael, M., Degos, L., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86: 1276-1280, 1995.
7. Ganem, D. KSHV and Kaposi's sarcoma: the end of the beginning? Cell, 91: 157-160, 1997.
8. Li, M., Lee, H., Yoon, D. W., Albrecht, J. C., Fleckenstein, B., Neipel, F., and Jung, J. U. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol., 71: 1984-1991, 1997.
9. Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden, K., Paterson, H., Weiss, R. A., and Mittnacht, S. Cyclin encoded by KS herpesvirus. Nature (Lond.), 382: 410, 1996.
10. Godden-Kent, D., Talbot, S. J., Boshoff, C., Chang, Y., Moore, P., Weiss, R. A., and Mitmacht, S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol., 71: 4193-4198, 1997.
11. Ellis, M., Chew, Y. P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R. A., Lu, X., and Mitmacht, S. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J., 18: 644-653, 1999.
12. Laman, H., Coverley, D., Krude, T., Laskey, R., and Jones, N. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol. Cell. Biol., 21: 624-635, 2001.
13. Mann, D. J., Child, E. S., Swanton, C., Laman, H., and Jones, N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J., 18: 654-663, 1999.
14. Swanton, C., Mann, D. J., Fleckenstein. B., Neipel, F., Peters, G., and Jones, N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature (Lond.), 390: 184-187, 1997.
15. Child, E. S., and Mann, D. J. Novel properties of the cyclin encoded by human herpesvirus 8 that facilitate exit from quiescence. Oncogene. 20: 3311-3322, 2001.
16. Jeffrey, P. D., Tong, L., and Pavletich, N. P. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev., 14: 3115-3125, 2000.
17. Kaldis, P., Ojala, P. M., Tong, L., Makela, T. P., and Solomon, M. J. CAK-independent activation of CDK6 by a viral cyclin. Mol. Biol. Cell, 12: 3987-3999, 2001.
18. Verschuren, E. W., Klefstrom, J., Evan, G. I., and Jones, N. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell, 2: 229-241, 2002.
19. Ojala, P. M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S. J., and Makela, T. P. The apoptotic v-cyclin-CDK6 complex phosphorylates, and inactivates Bcl-2. Nat. Cell. Biol., 2: 819-825. 2000.
20. Meyerson, M., and Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14: 2077-2086, 1994.
21. Garcia, I., Murga, M., Vicario, A., Field, S. J., and Zubiaga, A. M. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ., 11: 91-98, 2000.
22. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G., and Dowdy, S. F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature (Lond.), 407: 642-645, 2000.
23. Zhu, J. W., DeRyekere, D., Li, F. X., Wan, Y. Y., and DeGregori, J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ., 10: 829-838, 1999.
24. Brinster, R. L., Chen, H. Y., Trumbauer, M. E., Yagle, M. K., and Palmiter, R. D. Factors affecting the efficiency of introducing foreign DNA into mice by micronijecting eggs. Proc. Natl. Acad. Sci. USA, 82: 4438-4442, 1985.
25. Evan, G. L., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M. Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
26. Hackett, C. S., Hudgson, J. G., Law, M. E., Fridlyand, J., Osoegawa, K., de Jong, P. J., Nowak, N. J., Pinkel, D., Albertson, D. G., Jain, A., Jenkins, R., Gray, J. W., and Weiss, W. A. Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumurs. Cancer Res., 63: 5266-5273, 2003.
27. Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Nowak, N., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., and Gray, J. W. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet., 29: 459-464, 2001.
28. Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., and Adams, J. M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13: 2124-2130, 1994.
29. Grosschedl, R., Weaver, D., Baltimore, D., and Custantini, F. Intruduction of a mu immunoglubulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody. Cell, 38: 647-658, 1984.
30. Moroy, T., Fisher, P., Guidos, C., Ma, A., Zimmerman, K., Tesfaye, A., DePinho, R., Weissman, I., and Alt, F. W. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis. EMBO J., 9: 3659-3666, 1990.
31. Bronson, J. Rate of occurrence of lesions in 20 inbred and hyrid genotypes of rats and mice sacrificed at 6 months intervals during the first years of life. In: D. E. Harrison (ed.) Genetic Effects on Aging 11, pp. 279-358. Caldwell, NJ: Telford Press. 1990.
32. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
33. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
34. Pumerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., Cordon-Cardo, C., and DePinho, R. A. The Ink4a rumor suppressor gene product, p19Art, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
35. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., and Peters, G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17: 5001-5014, 1998.
36. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
37. Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumurigenesis in p53-deficient mice. Nat. Genet., 5: 225-229, 1993.
38. Morse, H. C., III, Anver, M. R., Fredrickson, T. N., Haines, D. C., Harris, A. W., Harris, N. L., Jaffe, E. S., Kogan, S. C., MacLennan, I. C., Pattengale, P. K., and Ward, J. M. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood, 100: 246-258, 2002.
39. Clarke, A. R., Purdie, C. A., Harrison, O. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
40. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
41. Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., and Cleveland, J. L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev., 13: 2658-2669, 1999.
42. Bates, S., Phillips, A. C., Clark, P. A., Slott, F., Peters, G., Ludwig, R. L., and Vousden, K. H. p14ARF links the tumour suppressors RB and p53. Nature (Lond.), 395: 124-125, 1998.
43. Lovec, H., Grzeschiczek, A., Kowalski, M. B., and Moroy, T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J., 13: 3487-3495, 1994.
44. van Dyk, L. F., Hess, J. L., Katz, J. D., Jacoby, M., Speck, S. H., and Virgin, H. I. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J. Virol., 73: 5110-5122, 1999.
45. Ensser, A., Glykofrydes, D., Niphuis, H., Kuhn, E. M., Rosenwirth, B., Heeney, J. L., Niedobitek, G., Muller-Fleckenstein, I., and Fleckenstein, B. Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J. Exp. Med., 193: 637-642, 2001.
46. Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., and Brinster, R. L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (Lond.), 318: 533-538, 1985.
47. Harris, A. W., Pinkert, C. A., Crawford, M., Langdon, W. Y., Brinster, R. L., and Adams, J. M. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med., 167: 353-371, 1988.
48. Iwamoto, T., Pu, M., Ito, M., Takahashi, M., Isobe, K., Nagase, F., Kawashima, K., Ichihara, M., and Nakashima, I. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice. Eur. J. Immunol., 21: 1809-1814, 1991.
49. Wasserman, R., Zeng, X. X., and Hardy, R. R. The evolution of B precursor leukemia in the E mu-ret mouse. Blood, 92: 273-282, 1998.
50. Engel, I., and Murre, C. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc. Natl. Acad. Sci. USA, 99: 11322-11327, 2002.
51. Fukasawa, K., Wiener, F., Vande Woude, G. F., and Mai, S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene. 15: 1295-1302, 1997.
52. Brinkley, B. R. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol., 11: 18-21, 2001.
53. Duensing, S., Duensing, A., Crum, C. P., and Munger, K. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res., 61: 2356-2360, 2001.
54. Levine, D. S., Sanchez, C. A., Rabinovitch, P. S., and Reid, B. J. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc. Natl. Acad. Sci. USA, 88: 6427-6431, 1991.
55. Marx, J. Cell biology. Do centrosome abnormalities lead to cancer? Science. 292: 426-429, 2001.
56. Gurova, K. V., Kwek, S. S., Koman, I. E., Komarov, A. P., Kandel, E., Nikiforov. M. A., and Gudkov, A. V. Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor. Cancer Biol. Ther., 1: 39-46, 2002.
57. Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., and Lowe, S. W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell, 1: 289-298, 2002.
58. Bisceglia, M., Bosman, C., and Quirke, P. A histologic and flow cytometric study of Kaposi's sarcoma. Cancer (Phila.), 69: 793-798, 1992.
59. Dictor, M., Ferno, M., and Baldetorp, B. Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma. Am. J. Epidemiol., 13: 201-208, 1991.
60. Kaaya, E. E., Parravicini, C., Sundelin, B., Mgaya, E., Kitinya, J., Lema. L., Luande, J., and Biberfeld, P. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur. J. Cancer. 11: 1890-1894, 1992.
61. Gill, P. S., Tsai, Y. C., Rao, A. P., Spruck, C. H., III, Zheng, T., Harrington, W. A., Jr., Cheung, T., Nathwani, B., and Jones, P. A. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA, 95: 8257-8261, 1998.
62. Judde, J. G., Lacoste, V., Briere, J., Kassa-Kelembho, E., Clyti, E., Couppie, P., Buchrieser, C., Tulliez, M., Morvan, J., and Gessain, A. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J. Natl. Cancer Inst., 92: 729-736, 2000.
63. Friborg, J., Jr., Kong, W., Hottiger, M. O., and Nabel, G. J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature (Lond.), 402: 889-894, 1999.
64. Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P., and Grandien, A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med., 190: 1025-1032, 1999.
65. Bergman, R., Ramon, M., Kilim, S., Lichtig, C., and Friedman-Birnbaum, R. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. Am. J. Dermatopathol., 18: 367-370, 1996.
66. Kalano, H., Sato, Y., and Sata, T. Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer (Phila.), 92: 3076-3084, 2001.
67. Kennedy, M. M., O'Leary, J. J., Oates, J. L., Lucas, S. B., Howells, D. D., Picton, S., and MeGee, J. O. Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression. Mol. Pathol., 51: 155-159, 1998.